Medisensonic S.A. Modern medical technologies with growing investment potential
January 23, 2025 10:26 ET
|
MediSensonic
WARSAW, Poland, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Medisensonic S.A., a Polish MedTech joint-stock company with an estimated market value of more than €15 million, is one of the very promising...
Integer Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 20, 2025
January 23, 2025 08:00 ET
|
Integer Holdings Corporation
PLANO, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full year...
Group FH ORTHO announced the Launch of JARVIS the New Round Baseplate for Reverse Prosthesis in the USA!
January 20, 2025 09:18 ET
|
Group FH Ortho
Group FH ORTHO announced the Launch of JARVIS the New Round Baseplate for Reverse Prosthesis in the USA!
Heimsbrunn, France, January 20th, 2025
Radical Catheter Technologies’ 8F Neurovascular Catheter Receives US FDA 510(k) Clearance, Second for the Best-in-Class Ribbon Technology Platform
January 15, 2025 09:00 ET
|
Radical Catheter Technologies
CAMPBELL, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Radical™ Catheter Technologies, a pioneering medical device company focused on advancing the next generation of endovascular access and delivery,...
E8, Inc. Announces Collaborative Partnership with Jacobs Institute to Make Minimally Invasive Solutions the Gold Standard in Neurosurgery
January 14, 2025 08:00 ET
|
E8, Inc.
LOS GATOS, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- E8, Inc. unveiled its next-generation suite of tools designed to turn the promise of minimally invasive neurosurgical access devices, including...
R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for the ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
January 13, 2025 06:00 ET
|
R3 Vascular
MOUNTAIN VIEW, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating...
PortIO Completes Keiretsu Forum MST Due Diligence, Paving the Way for Fast-Track Funding
January 08, 2025 07:25 ET
|
Keiretsu Forum Mid-Atlantic
PortIO Corp’s decision to engage K4-MST underscores Keiretsu’s proven track record of advancing life sciences and medical technology ventures.
electroCore Expands Intellectual Property Portfolio
January 07, 2025 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received five patent...
Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial
December 23, 2024 08:30 ET
|
Vivos Inc.
Richland, WA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- – Vivos Inc. (OTCQB: RDGL) proudly announces the initiation of its first human clinical trial for RadioGel® Precision Radionuclide Therapy™ in India....
Signati™ Medical Successfully Completes IDE Trial for Separo™ Vessel Sealing System and Initiates FDA Market Clearance Process
December 23, 2024 08:00 ET
|
Signati Medical Inc.
Providence, RI, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Signati™ Medical is proud to announce the successful completion of its Investigational Device Exemption (IDE) trial evaluating the Separo™ Vessel...